Merck Announces Third-Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Merck (MRK) tops Q3 expectations on sustained growth in oncology and vaccine segments
October 26, 2023 9:26 AM EDTMerck (NYSE: MRK) reported earnings before the open Thursday, topping both profit and revenue consensus expectations.
The pharmaceutical company reported earnings of $2.13 per share, $0.18 better than the analyst estimate of $1.95, while revenue for the quarter came in at $16 billion, up 7% YoY and above the consensus estimate of $15.29 billion.
The company... More
Merck (MRK) Tops Q3 EPS by 18c
October 26, 2023 6:32 AM EDTMerck (NYSE: MRK) reported Q3 EPS of $2.13, $0.18 better than the analyst estimate of $1.95. Revenue for the quarter came in at $16 billion versus the consensus estimate of $15.29 billion.
GUIDANCE:
Merck sees FY2023 EPS of $3.03-$3.08, ex items, versus the consensus of... More
